<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">vaccine </span>
   <span class="font21">[]. </span>
   <span class="font20">COVID- </span>
   <span class="font17">[], </span>
   <span class="font17">vaccines </span>
   <span class="font16">coronavirus </span>
   <span class="font16">phase </span>
   <span class="font14">Available </span>
   <span class="font14">from: </span>
   <span class="font14">clinical </span>
   <span class="font14">respiratory </span>
   <span class="font14">virus </span>
   <span class="font14">{border-style </span>
   <span class="font14">Phase </span>
   <span class="font14">[cited </span>
   <span class="font14">development </span>
   <span class="font13">Vaccine </span>
   <span class="font13">disease </span>
   <span class="font13">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">trial </span>
   <span class="font13">trials </span>
   <span class="font13">severe </span>
   <span class="font13">ClinicalTrials.gov. </span>
   <span class="font13">Identifier: </span>
   <span class="font13">NCT. </span>
   <span class="font13">protein </span>
   <span class="font12">Ebola </span>
   <span class="font12">https://clinicaltrials.gov/ct/show/NCT. </span>
   <span class="font12">novel </span>
   <span class="font12">inactivated </span>
   <span class="font12">viral </span>
   <span class="font12">DNA </span>
   <span class="font12">acute </span>
   <span class="font12">human </span>
   <span class="font12">mice </span>
   <span class="font12">new </span>
   <span class="font12">response </span>
   <span class="font12">syndrome </span>
   <span class="font12">vaccines: </span>
   <span class="font12">years; </span>
   <span class="font12">Infectious </span>
   <span class="font12">SARS-CoV- </span>
   <span class="font12">[]Participants: </span>
   <span class="font12">associated </span>
   <span class="font12">immune </span>
   <span class="font12">immunity </span>
   <span class="font12">patients </span>
   <span class="font12">safety </span>
   <span class="font11">Lancet </span>
   <span class="font11">SARS-CoV </span>
   <span class="font11">Trial </span>
   <span class="font11">Vaccines </span>
   <span class="font11">Candidate </span>
   <span class="font11">Clinical </span>
   <span class="font11">England </span>
   <span class="font11">Medicine </span>
   <span class="font11">SARS </span>
   <span class="font11">antibody </span>
   <span class="font11">antigen </span>
   <span class="font11">candidate </span>
   <span class="font11">developed </span>
   <span class="font11">epidemic </span>
   <span class="font11">global </span>
   <span class="font11">infectious </span>
   <span class="font11">mRNA </span>
   <span class="font11">outbreak </span>
   <span class="font11">px; </span>
   <span class="font11">recombinant </span>
   <span class="font11">research </span>
   <span class="font11">shown </span>
   <span class="font11">{font-family </span>
   <span class="font11">â€" </span>
   <span class="font11">Health </span>
   <span class="font11">I/II: </span>
   <span class="font11">MERS-CoV </span>
   <span class="font11">NCT </span>
   <span class="font11">age </span>
   <span class="font11">efficacy </span>
   <span class="font11">font-size </span>
   <span class="font11">humoral </span>
   <span class="font11">immunogenicity </span>
   <span class="font11">mortality </span>
   <span class="font11">responses </span>
   <span class="font11">target </span>
   <span class="font11">vector </span>
   <span class="font11">April </span>
   <span class="font11">BCG </span>
   <span class="font11">Diseases </span>
   <span class="font11">Global </span>
   <span class="font11">Immunogenicity </span>
   <span class="font11">acid </span>
   <span class="font11">candidates </span>
   <span class="font11">challenged </span>
   <span class="font11">double; </span>
   <span class="font11">early </span>
   <span class="font11">following </span>
   <span class="font11">including </span>
   <span class="font11">need </span>
   <span class="font11">nucleic </span>
   <span class="font11">participants </span>
   <span class="font11">pneumonia </span>
   <span class="font11">polio </span>
   <span class="font11">population </span>
   <span class="font11">spike </span>
   <span class="font11">use </span>
   <span class="font11">years </span>
   <span class="font11">East </span>
   <span class="font11">Elsevier </span>
   <span class="font11">Institute </span>
   <span class="font11">Recombinant </span>
   <span class="font11">Safety </span>
   <span class="font11">Study </span>
   <span class="font11">adults </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">cellular </span>
   <span class="font11">deployment </span>
   <span class="font11">dose </span>
   <span class="font11">effective </span>
   <span class="font11">effects </span>
   <span class="font11">humans </span>
   <span class="font11">immunopathology </span>
   <span class="font11">infected </span>
   <span class="font11">low </span>
   <span class="font11">manufacturing </span>
   <span class="font11">open-label, </span>
   <span class="font11">oral </span>
   <span class="font11">people </span>
   <span class="font11">prevention </span>
   <span class="font11">production </span>
   <span class="font11">rapid </span>
   <span class="font11">reported </span>
   <span class="font11">results </span>
   <span class="font11">showed </span>
   <span class="font11">solid; </span>
   <span class="font11">symptoms </span>
   <span class="font11">technology </span>
   <span class="font11">using </span>
   <span class="font11">vaccination </span>
   <span class="font11">vectors </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">ChiCTR </span>
   <span class="font10">China: </span>
   <span class="font10">Coronavirus </span>
   <span class="font10">Inactivated </span>
   <span class="font10">Middle </span>
   <span class="font10">Polio </span>
   <span class="font10">RNA </span>
   <span class="font10">Respiratory </span>
   <span class="font10">Viral </span>
   <span class="font10">World </span>
   <span class="font10">aged </span>
   <span class="font10">available </span>
   <span class="font10">bold </span>
   <span class="font10">cell </span>
   <span class="font10">centre </span>
   <span class="font10">challenge </span>
   <span class="font10">characteristics </span>
   <span class="font10">controlled </span>
   <span class="font10">courier; </span>
   <span class="font10">currently </span>
   <span class="font10">diseases </span>
   <span class="font10">effectiveness </span>
   <span class="font10">em; </span>
   <span class="font10">health </span>
   <span class="font10">infection </span>
   <span class="font10">licensed </span>
   <span class="font10">likely </span>
   <span class="font10">lung </span>
   <span class="font10">majority </span>
   <span class="font10">measles </span>
   <span class="font10">medicine </span>
   <span class="font10">n=; </span>
   <span class="font10">neutralizing </span>
   <span class="font10">pandemic </span>
   <span class="font10">platforms </span>
   <span class="font10">prior </span>
   <span class="font10">produced </span>
   <span class="font10">progress </span>
   <span class="font10">protection </span>
   <span class="font10">pt;} </span>
   <span class="font10">require </span>
   <span class="font10">resource </span>
   <span class="font10">risk </span>
   <span class="font10">safe </span>
   <span class="font10">speed </span>
   <span class="font10">studyThe </span>
   <span class="font10">trialThe </span>
   <span class="font10">trials. </span>
   <span class="font10">viruses </span>
  </p>
 </body>
</html>
